MEDILINKTHERA Trademark

Trademark Overview


On Monday, March 14, 2022, a trademark application was filed for MEDILINKTHERA with the United States Patent and Trademark Office. The USPTO has given the MEDILINKTHERA trademark a serial number of 97311053. The federal status of this trademark filing is REGISTERED as of Tuesday, February 21, 2023. This trademark is owned by MediLink Therapeutics(Suzhou)Co.,Ltd.. The MEDILINKTHERA trademark is filed in the Pharmaceutical Products category with the following description:

Disinfectants; Pesticides; Anti-infective products for veterinary use; Cotton for medical purposes; Dental lacquer; Depuratives for the body; Disinfectant wipes; Gases and gas mixtures for medical imaging use; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Medicinal preparations for anemia, cancer, cardiovascular system diseases, central nervous system diseases, peripheral nervous system diseases, circulatory system diseases, digestive system diseases, autoimmune diseases, bacteria-based diseases and infectious diseases; Nutritional food additives for medical purposes in the nature of natural food extracts derived from fish, meat and vegetables; Nutritional meal replacement bars adapted for medical use for individuals undergoing medical treatments; Nutritive substances for microorganisms for medical purposes; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of viral, ...
medilinkthera

General Information


Serial Number97311053
Word MarkMEDILINKTHERA
Filing DateMonday, March 14, 2022
Status700 - REGISTERED
Status DateTuesday, February 21, 2023
Registration Number6986332
Registration DateTuesday, February 21, 2023
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, December 6, 2022

Trademark Statements


Description of MarkThe mark consists of the stylized wording "MEDILINKTHERA".
Goods and ServicesDisinfectants; Pesticides; Anti-infective products for veterinary use; Cotton for medical purposes; Dental lacquer; Depuratives for the body; Disinfectant wipes; Gases and gas mixtures for medical imaging use; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Medicinal preparations for anemia, cancer, cardiovascular system diseases, central nervous system diseases, peripheral nervous system diseases, circulatory system diseases, digestive system diseases, autoimmune diseases, bacteria-based diseases and infectious diseases; Nutritional food additives for medical purposes in the nature of natural food extracts derived from fish, meat and vegetables; Nutritional meal replacement bars adapted for medical use for individuals undergoing medical treatments; Nutritive substances for microorganisms for medical purposes; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the prevention of anemia, cancer, cardiovascular system diseases, central nervous system diseases, peripheral nervous system diseases, circulatory system diseases, digestive system diseases, autoimmune diseases, bacteria-based diseases and infectious diseases; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations, namely, elixirs for the treatment of anemia, cancer, cardiovascular system diseases, central nervous system diseases, peripheral nervous system diseases, circulatory system diseases, digestive system diseases, autoimmune diseases, bacteria-based diseases and infectious diseases; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Sugar replacement for medicinal or therapeutic purposes; Therapeutic pharmaceutical for the treatment of anemia, cancer, cardiovascular system diseases, central nervous system diseases, peripheral nervous system diseases, circulatory system diseases, digestive system diseases, autoimmune diseases, bacteria-based diseases and infectious diseases; Veterinary preparations, namely, pain relief medication
Pseudo MarkMED LINK THERAPEUTICS
Indication of Colors claimedColor is not claimed as a feature of the mark.
Translation of Words in MarkThe wording "MEDILINKTHERA" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 18, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMediLink Therapeutics(Suzhou)Co.,Ltd.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressSuzhou, Jiangsu 215000
CN

Party NameMediLink Therapeutics(Suzhou)Co.,Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressSuzhou, Jiangsu 215000
CN

Party NameMediLink Therapeutics(Suzhou)Co.,Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSuzhou, Jiangsu 215000
CN

Trademark Events


Event DateEvent Description
Tuesday, February 21, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, February 21, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, December 6, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 6, 2022PUBLISHED FOR OPPOSITION
Wednesday, November 16, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 1, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, October 28, 2022ASSIGNED TO EXAMINER
Friday, March 18, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 17, 2022NEW APPLICATION ENTERED